CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −2,042 | $62.23 | $127K | 130,583 |
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −700 | $63.05 | $44K | 129,883 |
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −100 | $64.10 | $6K | 129,783 |
| 2018-11-12 | Mills Kenneth T. President and CEO | Sale | −13,586 | $62.85 | $854K | 292,414 |
| 2018-11-12 | Mills Kenneth T. President and CEO | Sale | −6,214 | $63.65 | $396K | 286,200 |
| 2018-11-12 | Mills Kenneth T. President and CEO | Sale | −200 | $64.30 | $13K | 286,000 |
| 2018-11-07 | Christmas Patrick J. SVP, General Counsel | Sale | −15,000 | $72.06 | $1.1M | 2,669 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +20,414 | $0.85 | $17K | 20,414 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Sale | −3,413 | $66.26 | $226K | 17,001 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Sale | −4,820 | $67.14 | $324K | 12,181 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Sale | −3,700 | $68.22 | $252K | 8,481 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Sale | −3,854 | $69.54 | $268K | 4,627 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Sale | −4,627 | $69.97 | $324K | 0 |
| 2018-11-05 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,414 | 81,658 | ||
| 2018-11-05 | Mills Kenneth T. President and CEO | Sale | −3,500 | $66.29 | $232K | 322,500 |
| 2018-11-05 | Mills Kenneth T. President and CEO | Sale | −4,816 | $67.16 | $323K | 317,684 |
| 2018-11-05 | Mills Kenneth T. President and CEO | Sale | −3,635 | $68.27 | $248K | 314,049 |
| 2018-11-05 | Mills Kenneth T. President and CEO | Sale | −3,340 | $69.47 | $232K | 310,709 |
| 2018-11-05 | Mills Kenneth T. President and CEO | Sale | −4,709 | $69.92 | $329K | 306,000 |
| 2018-11-02 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +32,908 | $13.09 | $431K | 170,191 |
Page 35 of 43 · 852 trades